Biosupply Trends Marketplace News
Friday 24, 2015
female doctor
biosupply button green pixel top of biosupply button
Biosupply, place your product order MyFluVaccine, place your vaccine order Verified Inventory Program, sign up for streamlined inventory

Flu Vaccine May Protect Against Guillain-Barré Syndrome

Medical Professional using test tube
 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare IVIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
Subscribe to the eBST Newsletter button

A new simulation study that evaluated the relationship between Guillain-Barré syndrome (GBS) risk and influenza vaccine and illness suggests that the vaccine reduces the risk for GBS. Researchers found that influenza vaccination reduces individual risk for GBS for most patients under typical conditions. [ read more ]

Safety in Medicine: Ensuring the Integrity of Drugs

The path drugs must travel to reach a patient, known as the supply or distribution chain, is a complicated one that too often results in adulteration and counterfeiting, posing a serious threat to public health and tragic consequences around the world. But, new laws and policies are being enacted globally to stem the growth of counterfeit and adulterated drugs caused by increases in globalization and the supply chain complexity. [ read more ]

(**Article will be available in the Spring 2015 BioSupply Trends Magazine)

Pediatrics Academy Updates Measles Recommendations

In response to the national measles outbreak, the American Academy of Pediatrics has released updated measles guidelines on its website. The new guidelines from the Academy's Red Book: 2015 Report of the Committee on Infectious Diseases weren't scheduled for publication until May, but the academy is making the chapter available online to give clinicians immediate access to the updated recommendations.
[ read more ]

Industry News

man in swimming pool

From Novo Nordisk

Novo Nordisk has launched Novoeight (antihemophilic factor [recombinant]) in the United States for treatment of people living with hemophilia A. [ read more ]

From Baxter BioScience

In March, Baxter received positive results from its Phase III clinical trial evaluating the safety and efficacy of BAX 817, an investigational recombinant factor VIIa (rFVIIa) treatment for people with hemophilia A or B who develop inhibitors.
[ read more ]

From Bayer Healthcare

The U.S. Food and Drug Administration has accepted Bayer Healthcare's Biologics License Application for BAY 81-8973 (proposed trade name Kovaltry), a recombinant factor VIII compound for the treatment of hemophilia A in children and adults.
[ read more ]

From Grifols

Grifols has made a major equity investment in Alkahest to work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system, including Alzheimer's disease. [ read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Supply Index from December - April 2015
 
 

New Products From FFF

Flublok 0.5 mL SDV (Protein Sciences)

Egg-free flu vaccine approved for individuals 18 years and older

Fluzone Intradermal Quadrivalent 0.1 mL PFS (Sanofi Pasteur)

Four-strain flu vaccine approved for individuals 18 years through 64 years

Vivotif (PaxVax)

Live oral typhoid vaccine indicated for for adults and children 6 years and older against disease caused by Salmonella typhi

Trumenba 0.5 mL SDV (Pfizer)

Meningococcal group B vaccine indicated for adults and children 10 years to 25 years

Gamunex-C 40 gram vial (Grifols)

Intravenous and subcutaneous immune globulin 40-gram vial size for the treatment of PI, ITP and CIDP

Nabi-HB 1 mL SDV and 5 mL SDV (Biotest Pharmaceuticals)

Hyperimmune globulin containing antibodies to hepatitis B surface antigen (anti-HBs) indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection

Sivextro Tedizolid Phosphate 200 mg tablet and IV vial (Cubist)

Antibacterial drug for the treatment of adults with skin infections and to reduce the development of drug-resistant bacteria

Tice BCG 50 mg SDV (Merck)

Intravesical vaccine for the treatment and prophylaxis of carcinoma in situ of the urinary bladder, and prophylaxis of stage Ta and/or T1 papillary tumor of the urinary bladder

Gardasil 9 0.5 ml PFS (Merck)

Human papillomavirus 9-valent vaccine approved for females ages 9 years through 26 years

Stratis Needle-Free Injection System 0.5 mL (PharmaJet)

Needle-free injection system that delivers vaccines either intramuscularly or subcutaneously by means of a narrow, precise fluid stream syringe that delivers the medicine or vaccine through the skin. *Only approved for use with AFLURIA 5 ML 10 DS VIAL.

FFF Enterprises offers a wide array of plasma products, vaccines and critical-care biopharmaceuticals, to view our complete list of products visit our website – Product Catalog. These products can be ordered by calling Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG Rates

Rates per gram are effective April 1, 2015 through June 30, 2015.

Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
Bivigam J1556 72.70 71.53
Carimune NF J1556 57.90 56.97
Flebogamma J1556 71.09 69.95
Gammagard Liquid J1556 78.41 77.16
Gammagard S/D J1556 57.90 56.97
Gammaked J1556 79.81 78.53
Gammaplex J1556 72.76 71.59
Gamunex-C J1556 79.81 78.53
Octagam J1556 81.11 79.81
Privigen J1556 74.90 73.70

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

Resources

FFF customers may order the following complementary resources to help you with your practice:

Seasonal Flu Poster flu myths and facts brochure
immune globulin reference charts
•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to IG Living
IG Living Magazine cover
BioSupplyTrends Quarterly Magazine cover

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Subscribe to Biosupply Trends Quarterly Magazine
Nufactor Logo Strip Verified Inventory Program logo Vax America logo small MyFluVaccine logo
Home | About | Advertise | Subscribe | Contact – ©2015 FFF Enterprises, Inc.
This email was sent by: %%Member_Busname%%, %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Manage preferences: Privacy Policy, Update Profile, Unsubscribe.